Research Article

Pirfenidone Inhibits Hypoxic Pulmonary Hypertension through the NADPH/ROS/p38 Pathway in Adventitial Fibroblasts in the Pulmonary Artery

Figure 2

PFD treatment reduced HPAAF migration after 12 h or 24 h hypoxia exposure. HPAAFs were stimulated by PFD before hypoxia, and cell migration was analyzed by wound healing assay. (a, b) Results and quantification of wound healing assay in HPAAFs following 12 h and 24 h of treatment (). vs. normoxia; vs. hypoxia; vs. hypoxia. PFD: pirfenidone; HPAAFs: human pulmonary arterial adventitial fibroblasts.
(a)
(b)